@FiercePharma: Tuesday's top news: Breakthrough hep C meds aren't yet for sale, but critics already taking aim at prices. Story | Follow @FiercePharma
@EricPFierce: Actavis takes aim at North Carolina plant, 310 jobs, as it looks to cut costs. More | Follow @EricPFierce
@CarlyHFierce: CFR chief angles for meeting with Adcock Ingram after top investor nixes $1.3B deal. Story | Follow @CarlyHFierce
> Dendreon ($DNDN) CFO Greg Schiffman has jumped ship to StemCells, where he will take over as CFO and executive vice president of finance. Release
> India's Sun Pharma hiked its outlook for fiscal 2014 revenue growth to 25% from its previously forecast 18-20%; its quarterly net sales grew by 58% to 41.92 billion rupees, or $664 million. Report
> Despite an extended period of shutdowns and cutbacks in the region, drugmakers still account for a $26.6 billion boost to the New Jersey economy. Report
> India's Strides Arcolab saw third-quarter profits slump because of foreign exchange losses and regulatory delays, but the company stuck to its forecast for the year. Report
> Novartis' ($NVS) generics unit Sandoz recalled a mispackaged batch of tuberculosis drugs from 5 states in India. Report
> The Slovenian drugmaker Krka posted a 12% increase in profits for the first 9 months of the year, to $1.67 million. Report
@FierceMedDev: Analysts: Volcano could be an M&A fit for Abbott, Medtronic. More | Follow @FierceMedDev
@MarkHFierce: Inspired by a wine cork removal device, an Argentinian mechanic developed a surgical tool to aid difficult births. Story | Follow @MarkHFierce
@MichaelGFierce: From FierceDrugDelivery: DNA-delivering patch spurs bone growth. Piece | Follow @MichaelGFierce
> Tandem banks $120M in topped-out IPO, stirring med tech market hopes. Article
> Biomet hit with metal hip lawsuit in Canada. More
Biotech News
@FierceBiotech: Merck KGaA says big M&A could jump-start stilted pipeline. Story | Follow @FierceBiotech
@JohnCFierce: Best case scenario for Lemtrada: FDA OKs for a very limited group of desperate patients. | Follow @JohnCFierce
@DamianFierce: Sanofi gets mixed FDA blessing for MS drug Lemtrada. More | Follow @DamianFierce
@EmilyMFierce: Tuberculosis R&D dropped by $30.4 million in 2012 compared with 2011. Report | Follow @EmilyMFierce
> Trio of IPO setbacks strike sour note at biotech's Wall Street party. News
> Novartis, Novavax whip up new bird flu vaccines as pandemic fears flourish. Article
> Theravance scraps ADHD program after drug flunks PhII study. More
Vaccines News
> Agenus, Sanofi-NIH collaboration race to develop genital herpes vaccine. Story
> Novartis to sell first piece of vaccine unit in $1.7B deal. Article
> Polio outbreak sparks fears refugees will carry virus to Europe. Report
> Dendreon to lay off more staff as Provenge disappoints. Again. More
> Novavax presents positive Phase I data for H7N9 vaccine. Story
> U.K. adds schools to flu data-gathering project. Item
Pharma Manufacturing News
> Track-and-trace bill may be finished this week. Article
> Lilly to invest $700M in plant expansions. More
> Sandoz pulls some TB drugs in India. Report
> Dendreon hopes manufacturing can save the day. Story
> FDA red-flags dangerous counterfeit ED product. Article
> New manufacturing processes could produce bird flu vax ASAP. Item
And Finally... Diabetes now kills one person every 6 seconds and affects 382 million people worldwide. Report